Invesco Biotechnology & Genome ETF
PBE
PBE
81 hedge funds and large institutions have $59.7M invested in Invesco Biotechnology & Genome ETF in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 27 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
52% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 27
Holders
81
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$701K | |
| 2 | +$242K | |
| 3 | +$231K | |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$211K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$208K |
Top Sellers
| 1 | -$1.88M | |
| 2 | -$777K | |
| 3 | -$731K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$730K |
| 5 |
COF
Capital One Financial
Mclean,
Virginia
|
-$504K |